Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024

PTN

CRANBURY, N.J., May 9, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter fiscal year 2024 operating results on Wednesday, May 15, 2024, before the open of the U.S. financial markets.

Palatin Technologies, Inc.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 15, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast


Q3 Fiscal Year 2024 Results Press Release

5/15/2024 at 7:30 a.m. ET

Q3 Fiscal Year 2024 Conference Call-Live
US Toll Free Dial-In Number:
International Dial-In Number:
Participant Access Code:

5/15/2024 at 11:00 a.m. ET
1-877-545-0523
1-973-528-0016
720217

Q3 Fiscal Year 2024 Conference Call-Replay
US Toll Free Dial-In Number:
International Dial-In Number:
Participant Access Code:

5/15/2024-5/29/2024
1-877-481-4010
1-919-882-2331
50601

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.

About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-third-quarter-fiscal-year-2024-results-teleconference-and-webcast-to-be-held-on-may-15-2024-302140923.html

SOURCE Palatin Technologies, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today